AstraZeneca’s AZD0780 is an investigational oral medication that was developed to lower low-density lipoprotein cholesterol ...

Coming this weekend, the American College of Cardiology (ACC) annual conference will feature research exploring new frontiers for GLP-1 drugs in cardiovascular medicine, and foundational answers are ...

Here are the biggest stories out of ACC 2025: Five-year data from the Medtronic Evolut Low Risk Trial confirmed that its ...

People at high risk for recurrent cardiac events following percutaneous coronary intervention (PCI), a procedure to open ...

Late-breaking data showed almost all patients achieved normal blood clotting and vessel repair after bentracimab infusion.

A BLA has been filed for bentracimab and, if approved, has the potential to be the first therapy to reverse the effects of ...

While little new information has become available, the 2005 guidelines reinforce the critical role that diuretics play in the management of symptomatic HF. Diuretics are recommended for all ...